Speaker illustration

Doctor Krisztina Szabo

University of Debrecen, Debrecen (Hungary)

Member of:

European Society of Cardiology

Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Clinical heart failure from diagnostics to treatment


The effectiveness of ARNI medication in patients, non-responder to cardiac resynchronization therapy

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Heart failure pharmacotherapy - Sacubitril/valsartan


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb